Of note was the demonstration that KMT1C downregulates the expression of Bcl-G (a proapoptotic gene) and inhibits apoptosis through the p53 tumour suppressor gene leading to HCC development [65]. This evidence concerns the gene EHMT2 and hepatocellular carcinoma.